FDMT. – 4D Molecular Therapeutics Inc
4D Molecular Therapeutics, Inc.FDMT
$8.21Name : 4D Molecular Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $383,427,264.00
EPSttm : -3.53
4D Molecular Therapeutics, Inc.
$8.21
2.26%$0.19Float Short %
11.01
Margin Of Safety %
Put/Call OI Ratio
0.14
EPS Next Q Diff
0.09
EPS Last/This Y
-0.71
EPS This/Next Y
-0.11
Price
8.37
Target Price
31.12
Analyst Recom
1.7
Performance Q
99.05
Relative Volume
0.39
Beta
2.92
Ticker: FDMT
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-09-08 | FDMT | 6.97 | 0.06 | 0.20 | 5521 |
| 2025-09-09 | FDMT | 6.98 | 0.06 | 0.13 | 5608 |
| 2025-09-10 | FDMT | 6.95 | 0.06 | 0.03 | 5640 |
| 2025-09-11 | FDMT | 7.07 | 0.06 | 0.48 | 5760 |
| 2025-09-12 | FDMT | 6.8 | 0.07 | 0.20 | 5750 |
| 2025-09-15 | FDMT | 6.87 | 0.07 | 0.32 | 5856 |
| 2025-09-16 | FDMT | 6.68 | 0.07 | 0.08 | 5853 |
| 2025-09-17 | FDMT | 6.66 | 0.072210065645514 | 0.2037037037037 | 5880 |
| 2025-09-18 | FDMT | 7.1 | 0.07 | 0.04 | 5881 |
| 2025-09-19 | FDMT | 6.61 | 0.08 | 0.03 | 5675 |
| 2025-09-22 | FDMT | 7.41 | 0.11 | 0.11 | 3456 |
| 2025-09-23 | FDMT | 7.61 | 0.11 | 0.26 | 3616 |
| 2025-09-24 | FDMT | 8.45 | 0.12 | 0.04 | 3747 |
| 2025-09-25 | FDMT | 8.42 | 0.12 | 0.08 | 3788 |
| 2025-09-26 | FDMT | 8.4 | 0.13 | 0.02 | 3749 |
| 2025-09-29 | FDMT | 8.35 | 0.13 | 0.00 | 3777 |
| 2025-09-30 | FDMT | 8.69 | 0.13 | 0.00 | 3778 |
| 2025-10-01 | FDMT | 8.73 | 0.13 | 0.01 | 3796 |
| 2025-10-02 | FDMT | 8.68 | 0.13 | 0.21 | 3818 |
| 2025-10-03 | FDMT | 8.55 | 0.13 | 2.29 | 3817 |
| 2025-10-06 | FDMT | 8.39 | 0.14 | 1.11 | 3700 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-09-08 | FDMT | 6.97 | -24.6 | - | -3.69 |
| 2025-09-09 | FDMT | 6.97 | -24.6 | - | -3.69 |
| 2025-09-10 | FDMT | 6.95 | -24.6 | - | -3.69 |
| 2025-09-11 | FDMT | 7.07 | -24.6 | - | -3.69 |
| 2025-09-12 | FDMT | 6.81 | -24.6 | - | -3.69 |
| 2025-09-15 | FDMT | 6.80 | -24.6 | - | -3.69 |
| 2025-09-16 | FDMT | 6.69 | -24.6 | - | -3.69 |
| 2025-09-17 | FDMT | 6.66 | -24.6 | - | -3.69 |
| 2025-09-18 | FDMT | 7.11 | -24.6 | - | -3.69 |
| 2025-09-19 | FDMT | 6.61 | -24.6 | - | -3.69 |
| 2025-09-22 | FDMT | 7.40 | -24.6 | - | -3.69 |
| 2025-09-23 | FDMT | 7.59 | -24.6 | - | -3.69 |
| 2025-09-24 | FDMT | 8.46 | -24.6 | - | -3.69 |
| 2025-09-25 | FDMT | 8.42 | -24.6 | - | -3.69 |
| 2025-09-26 | FDMT | 8.39 | -24.6 | - | -3.69 |
| 2025-09-29 | FDMT | 8.33 | -24.6 | - | -3.69 |
| 2025-09-30 | FDMT | 8.67 | -24.6 | - | -3.69 |
| 2025-10-01 | FDMT | 8.73 | -24.6 | - | -3.69 |
| 2025-10-02 | FDMT | 8.66 | -24.6 | - | -3.69 |
| 2025-10-03 | FDMT | 8.57 | -24.6 | - | -3.69 |
| 2025-10-06 | FDMT | 8.37 | -24.6 | - | -3.69 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-09-08 | FDMT | 0.00 | -9.04 | 9.72 |
| 2025-09-09 | FDMT | 0.00 | -9.04 | 9.72 |
| 2025-09-10 | FDMT | 0.00 | -9.04 | 9.72 |
| 2025-09-11 | FDMT | 0.00 | -9.04 | 10.08 |
| 2025-09-12 | FDMT | 0.00 | -9.04 | 10.08 |
| 2025-09-15 | FDMT | 0.00 | -8.99 | 10.08 |
| 2025-09-16 | FDMT | 0.00 | -8.99 | 10.08 |
| 2025-09-17 | FDMT | 0.00 | -8.99 | 10.08 |
| 2025-09-18 | FDMT | 0.00 | -8.99 | 10.08 |
| 2025-09-19 | FDMT | 0.00 | -8.99 | 10.08 |
| 2025-09-22 | FDMT | 0.00 | -8.99 | 10.08 |
| 2025-09-23 | FDMT | 0.00 | -8.99 | 10.08 |
| 2025-09-24 | FDMT | 0.00 | -8.99 | 10.08 |
| 2025-09-25 | FDMT | 0.00 | -8.99 | 11.01 |
| 2025-09-26 | FDMT | 0.00 | -8.99 | 11.01 |
| 2025-09-29 | FDMT | -0.06 | -8.99 | 11.01 |
| 2025-09-30 | FDMT | -0.06 | -8.99 | 11.01 |
| 2025-10-01 | FDMT | -0.06 | -8.99 | 11.01 |
| 2025-10-02 | FDMT | -0.06 | -8.99 | 11.01 |
| 2025-10-03 | FDMT | -0.06 | -8.99 | 11.01 |
| 2025-10-06 | FDMT | -0.06 | -6.78 | 11.01 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.98
Avg. EPS Est. Current Quarter
-0.98
Avg. EPS Est. Next Quarter
-0.89
Insider Transactions
-0.06
Institutional Transactions
-6.78
Beta
2.92
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
1
Fair Value
Quality Score
18
Growth Score
31
Sentiment Score
49
Actual DrawDown %
84.8
Max Drawdown 5-Year %
Target Price
31.12
P/E
Forward P/E
PEG
P/S
13076.82
P/B
0.93
P/Free Cash Flow
EPS
-3.71
Average EPS Est. Cur. Y
-3.69
EPS Next Y. (Est.)
-3.81
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-594375.76
Relative Volume
0.39
Return on Equity vs Sector %
-71.7
Return on Equity vs Industry %
-58.1
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
4D Molecular Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 227
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. Its lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. The company is also developing 4D-710, which is in early-stage study for the treatment of cystic fibrosis; 4D-175 that is in in preclinical stage for treating geographic atrophy; 4D-725, which is in preclinical stage for the treatment of alpha-1 anti-trypsin deficiency lung disease; and 4D-310 that is in Phase 1 clinical trial for treating Fabry disease. 4D Molecular Therapeutics, Inc. has collaboration and licensing agreements with Astellas Gene Therapies, Inc.; Arbor Biotechnologies, Inc.; and uniQure biopharma B.V. The company was founded in 2013 and is headquartered in Emeryville, California.
stock quote shares FDMT. – 4D Molecular Therapeutics Inc Stock Price stock today
news today FDMT. – 4D Molecular Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FDMT. – 4D Molecular Therapeutics Inc yahoo finance google finance
stock history FDMT. – 4D Molecular Therapeutics Inc invest stock market
stock prices FDMT premarket after hours
ticker FDMT fair value insiders trading